132 related articles for article (PubMed ID: 12795162)
1. [Experience with the memotherm stent in high-risk urinary retention patients].
Maru N; Shitara T; Yamashita H; Minei S; Shimura S; Hamashima T; Baba S
Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):481-6. PubMed ID: 12795162
[TBL] [Abstract][Full Text] [Related]
2. [Initial experiences with the Memotherm Stent in treatment of benign prostatic hyperplasia].
Gottfried HW; Schimers HP; Gschwend J; Brändle E; Hautmann R
Urologe A; 1995 Mar; 34(2):110-8. PubMed ID: 7538708
[TBL] [Abstract][Full Text] [Related]
3. Experience with the Memotherm permanently implanted prostatic stent.
Williams G; White R
Br J Urol; 1995 Sep; 76(3):337-40. PubMed ID: 7551842
[TBL] [Abstract][Full Text] [Related]
4. A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent.
Bozkurt IH; Yalcinkaya F; Sertcelik MN; Zengin K; Ekici M; Yigitbasi O
Urology; 2013 Nov; 82(5):1004-7. PubMed ID: 23992964
[TBL] [Abstract][Full Text] [Related]
5. The titanium intraprostatic stent: the United States experience.
Kaplan SA; Merrill DC; Mosely WG; Benson RC; Chiou RK; Fuselier HA; Parra RO
J Urol; 1993 Nov; 150(5 Pt 2):1624-9. PubMed ID: 7692099
[TBL] [Abstract][Full Text] [Related]
6. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.
Gesenberg A; Sintermann R
J Urol; 1998 Jul; 160(1):72-6. PubMed ID: 9628608
[TBL] [Abstract][Full Text] [Related]
7. [Outcome analysis of the urethral stent (Memotherm®)].
Sakamoto H; Matsuda A; Arakaki R; Yamada H
Hinyokika Kiyo; 2012 Jan; 58(1):13-6. PubMed ID: 22343737
[TBL] [Abstract][Full Text] [Related]
8. A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate.
Pétas A; Talja M; Tammela T; Taari K; Lehtoranta K; Välimaa T; Törmälä P
J Urol; 1997 Jan; 157(1):173-6. PubMed ID: 8976244
[TBL] [Abstract][Full Text] [Related]
9. Intraurethral stent prosthesis in spinal cord injured patients with sphincter dyssynergia.
Juan García FJ; Salvador S; Montoto A; Lion S; Balvis B; Rodríguez A; Fernández M; Sánchez J
Spinal Cord; 1999 Jan; 37(1):54-7. PubMed ID: 10025697
[TBL] [Abstract][Full Text] [Related]
10. Thermosensitive stent (Memotherm) for the treatment of benign prostatic hyperplasia.
Gottfried HW; Schlmers HP; Gschwend J; Brändle E; Hautmann RE
Arch Esp Urol; 1994 Nov; 47(9):933-43; discussion 943-6. PubMed ID: 7530951
[TBL] [Abstract][Full Text] [Related]
11. The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate.
Pétas A; Talja M; Tammela TL; Taari K; Välimaa T; Törmälä P
Br J Urol; 1997 Sep; 80(3):439-43. PubMed ID: 9313664
[TBL] [Abstract][Full Text] [Related]
12. A urethral stent for the treatment of detrusor-striated sphincter dyssynergia.
Chartier-Kastler EJ; Thomas L; Bussel B; Chancellor MB; Richard F; Denys P
BJU Int; 2000 Jul; 86(1):52-7. PubMed ID: 10886083
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
[TBL] [Abstract][Full Text] [Related]
14. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
[TBL] [Abstract][Full Text] [Related]
15. A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia.
Djavan B; Fakhari M; Shariat S; Ghawidel K; Marberger M
J Urol; 1999 Jan; 161(1):144-51. PubMed ID: 10037387
[TBL] [Abstract][Full Text] [Related]
16. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications.
Alivizatos G; Ferakis N; Mitropoulos D; Skolarikos A; Livadas K; Kastriotis I
J Endourol; 2005; 19(1):72-8. PubMed ID: 15735388
[TBL] [Abstract][Full Text] [Related]
17. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
[TBL] [Abstract][Full Text] [Related]
18. The use of a removable stent in patients with prostate cancer and obstruction.
Yachia D; Aridogan IA
J Urol; 1996 Jun; 155(6):1956-8. PubMed ID: 8618296
[TBL] [Abstract][Full Text] [Related]
19. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
[TBL] [Abstract][Full Text] [Related]
20. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
